Skip to search formSkip to main contentSkip to account menu

pomalidomide 4 MG Oral Capsule

Known as: POMALIDOMIDE 4MG CAP,ORAL, POMALIDOMIDE 4MG CAP,ORAL [VA Product], POMALIDOMIDE 4MG ORAL CAP 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
OPTIMISMM is the only phase III trial to show a significant PFS benefit in R/R MM patients with prior exposure to lenalidomide.